US-based Alamar Biosciences expands commercial support in Asia Pacific region

Alamar Biosciences, a US-based company powering precision proteomics to enable the earliest detection of disease, has an...

March 20, 2025 | Thursday | News
Vatech and Pearl join forces to revolutionise dental diagnosis with AI integration

South Korea-based Vatech, a global leader in dental imaging solutions, and Pearl, a frontrunner in dental AI technology ...

March 20, 2025 | Thursday | News
Novotech strengthens clinical trial capabilities in South Korea

Novotech, a global leading full-service clinical Contract Research Organization (CRO), and Acrostar, a provider of Site ...

March 19, 2025 | Wednesday | News
Lunit secures 5-year contract with SEHA in UAE for AI-based breast cancer screening programme

South Korea-based Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnostics and...

March 19, 2025 | Wednesday | News
LOTTE BIOLOGICS signs a strategic partnership agreement with Asimov

LOTTE BIOLOGICS has signed a Memorandum of Understanding (MOU) with Asimov, a company headquartered in Boston, Massachus...

March 17, 2025 | Monday | News
BIOPLUS-INTERPHEX KOREA 2025: Pioneering the Future of Biopharma with Specialized Pavilions

Showcasing Innovation Through Specialized Pavilions BIX 2025 will spotlight four specialized pavilions, each dedicated ...

March 17, 2025 | Monday | News
Sartorius to open cell culture media facility in Korea by 2027

To better meet customer demand, particularly in the Asia Pacific region, and to expand regional value creation, Sartoriu...

March 14, 2025 | Friday | News
Korea's Samsung invests $10 M in US-based C2N Diagnostics to strengthen brain healthcare

US-based C2N Diagnostics, LLC, a specialty diagnostics company with a vision to bring Clarity Through Innovation, h...

March 14, 2025 | Friday | News
ENCell signs MoU with Cell Resources Corp to pave way for market entry in Japan

ENCell Co., Ltd., a South Korean biotech company specialising in advanced biopharmaceutical contract development and man...

March 14, 2025 | Friday | News
SK bioscience expands global reach with influenza vaccine exports to Southern Hemisphere

South Korea-based SK bioscience, a global innovative vaccine and biotech company committed to promoting human health fro...

March 13, 2025 | Thursday | News
WuXi XDC and AbTis announce strategic partnership to advance next-generation ADCs

WuXi XDC Cayman Inc., a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specialisi...

March 11, 2025 | Tuesday | News
Seoul Medical Group and Korean American Medical Group merge into one

Seoul Medical Group (SMG) and Korean American Medical Group (KAMG), the two leading Asian-American-focused medical group...

March 10, 2025 | Monday | News
Korea designs advanced AI model for accelerating therapeutic gene target discovery

Identifying therapeutic gene targets is essential for advancing personalised medicine and addressing the genetic basis o...

March 7, 2025 | Friday | News
Lunit expands partnership with Saudi Arabia's largest medical group to deploy AI chest X-ray solution

South Korea-based startup Lunit, a leading provider of artificial intelligence (AI)-powered solutions for cancer diagnos...

March 7, 2025 | Friday | News
SK Chemicals inks agreement with Viatris to expand pain management portfolio in Korea

SK Chemicals, which developed Korea's first herbal medicine product for osteoarthritis, Joins, has expanded its pai...

March 6, 2025 | Thursday | News
Taiwan's Formosa Group invests $12.5 M to establish biomedical research centre in Korea

Taiwan-based Formosa Group Executive Committee member and Chairman Sandy Wang, who leads the group's bio and eco-friendl...

March 5, 2025 | Wednesday | News
Korea develops novel 3D adipose tissue bioprinting method

Adipose tissues, which serve as fat reserves, have been recognised as an endocrine organ. The three-dimensional (3D) bio...

March 4, 2025 | Tuesday | News
How Degrader-Antibody Conjugates Are Transforming Precision Medicine for Oncology & Beyond

Degrader-antibody conjugates (DACs) represent a natural evolution in targeted precision medicines for oncology and other...

March 1, 2025 | Saturday | Opinion

Podcast

Survey Box

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls